Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

NNVC - NanoViricides Inc Stock Price, Fair Value and News

$1.30-0.03 (-2.26%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

NNVC Price Action

Last 7 days

-8.5%

Last 30 days

13.0%

Last 90 days

8.3%

Trailing 12 Months

8.3%

NNVC Stock Price

NNVC RSI Chart

AugSepOctNovDec2025FebMarAprMay10203040506070

NNVC Valuation

Market Cap

20.3M

Price/Earnings (Trailing)

-2.17

EV/EBITDA

-2.78

Price/Free Cashflow

-2.42

MarketCap/EBT

-3.02

NNVC Price/Sales (Trailing)

2012201420162018202002K4K6K8K

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NNVC Fundamentals

NNVC Earnings

Earnings (TTM)

-9.4M

Earnings Growth (Yr)

4.13%

Earnings Growth (Qtr)

35.16%

201020152020-14M-12M-10M-8M-6M-4M-2M

NNVC Profitability

Return on Equity

-90.16%

Return on Assets

-80.94%

Free Cashflow Yield

-41.31%

NNVC Investor Care

Shares Dilution (1Y)

32.79%

Diluted EPS (TTM)

-0.72

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs

About NanoViricides Inc

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.
 CEO
 WEBSITEnanoviricides.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES17

NanoViricides Inc Frequently Asked Questions

What is the ticker symbol for NanoViricides Inc? What does NNVC stand for in stocks?

NNVC is the stock ticker symbol of NanoViricides Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NanoViricides Inc (NNVC)?

As of Fri May 02 2025, market cap of NanoViricides Inc is 20.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NNVC stock?

You can check NNVC's fair value in chart for subscribers.

Is NanoViricides Inc a good stock to buy?

The fair value guage provides a quick view whether NNVC is over valued or under valued. Whether NanoViricides Inc is cheap or expensive depends on the assumptions which impact NanoViricides Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NNVC.

What is 5 year return on NanoViricides Inc's stock?

In the past 10 years, NanoViricides Inc has provided -0.281 (multiply by 100 for percentage) rate of return.